Virtuals Protocol has introduced a 60-day trial framework that changes how early crypto projects launch while VIRTUAL token is up almost 3%. The post Virtuals ProtocolVirtuals Protocol has introduced a 60-day trial framework that changes how early crypto projects launch while VIRTUAL token is up almost 3%. The post Virtuals Protocol

Virtuals Protocol Debuts 60-Day Trial for Founders, VIRTUAL Shows Signs of Life

3 min read

Virtuals Protocol VIRTUAL $0.64 24h volatility: 2.2% Market cap: $421.06 M Vol. 24h: $79.67 M has introduced a new launch framework called “60 Days,” giving early-stage founders a reversible way to test products, tokens, and market demand.

Instead of forcing immediate and permanent commitment, founders build publicly for 60 days while capital forms through trading activity and optional growth pools.

At the end of the window, founders choose whether to commit. If they commit, funds unlock over time and the project continues.

If they don’t, the token winds down and all eligible funds are returned to holders. The framework removes the usual one-way risk tied to early token launches.

How the 60 Days Mechanism Works

Each project launches a token on the Base network using a standard bonding curve. Tokens trade during the 60-day trial while founders ship updates, engage users, publish metrics, and collect feedback.

Projects begin in private pools. Once cumulative volume reaches 42,000 VIRTUAL, liquidity migrates to a Uniswap V2 pool for open trading.

All trades carry a 1% fee and 30% goes to the protocol while 70% is allocated to the founder but remains locked during the trial.

If the founder commits, those funds unlock. If not, they are redirected into the refund pool.

Capital Formation and Founder Support

Virtuals uses Automated Capital Formation (ACF) to allocate funds to founders based on trading activity.

Released ACF funds support operations and early scaling. Unreleased allocations stay locked and are excluded from refunds until formally released.

Founders may also open a Growth Allocation pool by selling up to 5% of team tokens at a fixed valuation.

These funds are held in escrow and fully refunded if the founder does not commit. If the founder commits, Growth Allocation tokens vest linearly over six months.

To cover living and operating costs, founders receive stipends every 30 days. The stipend equals 10% of collected funds from founder trading fees and released ACF, capped at $5,000 USDC per payout.

It is important to note founders can commit early or wait until Day 60. A commitment unlocks founder trading fees, releases ACF funds, and starts Growth Allocation vesting.

If the founder does not commit, liquidity is drained, token issuance stops, and refunds trigger automatically.

VIRTUAL Attempts a Comeback

VIRTUAL token is up almost 3% in the past 24 hours, currently trading at $0.6374. However, the token has dropped more than 20% in the last 30 days alone.

The chart below shows prices below a descending trendline and the main demand zone sits near the $0.60 area.

VIRTUAL price chart with momentum indicators. | Source: TradingView

VIRTUAL price chart with momentum indicators. | Source: TradingView

If VIRTUAL holds the current support and breaks the descending trendline, a test of the $0.95 to $1.50 range is possible. However, A clean break below support would expose the $0.38 area.

next

The post Virtuals Protocol Debuts 60-Day Trial for Founders, VIRTUAL Shows Signs of Life appeared first on Coinspeaker.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29